1. Home
  2. SPRB vs GFAI Comparison

SPRB vs GFAI Comparison

Compare SPRB & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • GFAI
  • Stock Information
  • Founded
  • SPRB 2014
  • GFAI 2018
  • Country
  • SPRB United States
  • GFAI Singapore
  • Employees
  • SPRB N/A
  • GFAI N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • GFAI Diversified Commercial Services
  • Sector
  • SPRB Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • SPRB Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • SPRB 15.7M
  • GFAI 17.9M
  • IPO Year
  • SPRB 2020
  • GFAI N/A
  • Fundamental
  • Price
  • SPRB $0.33
  • GFAI $1.00
  • Analyst Decision
  • SPRB Hold
  • GFAI Strong Buy
  • Analyst Count
  • SPRB 7
  • GFAI 2
  • Target Price
  • SPRB $2.17
  • GFAI $6.75
  • AVG Volume (30 Days)
  • SPRB 300.3K
  • GFAI 698.3K
  • Earning Date
  • SPRB 03-21-2025
  • GFAI 04-28-2025
  • Dividend Yield
  • SPRB N/A
  • GFAI N/A
  • EPS Growth
  • SPRB N/A
  • GFAI N/A
  • EPS
  • SPRB N/A
  • GFAI N/A
  • Revenue
  • SPRB $7,101,000.00
  • GFAI $35,841,743.00
  • Revenue This Year
  • SPRB N/A
  • GFAI $0.37
  • Revenue Next Year
  • SPRB N/A
  • GFAI $5.60
  • P/E Ratio
  • SPRB N/A
  • GFAI N/A
  • Revenue Growth
  • SPRB N/A
  • GFAI 1.78
  • 52 Week Low
  • SPRB $0.33
  • GFAI $0.94
  • 52 Week High
  • SPRB $1.29
  • GFAI $4.30
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 27.09
  • GFAI 35.17
  • Support Level
  • SPRB $0.34
  • GFAI $0.98
  • Resistance Level
  • SPRB $0.36
  • GFAI $1.08
  • Average True Range (ATR)
  • SPRB 0.03
  • GFAI 0.09
  • MACD
  • SPRB -0.01
  • GFAI -0.00
  • Stochastic Oscillator
  • SPRB 2.70
  • GFAI 6.06

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks: